Arteriovenous Malformation clinical trials at UCSF

1 research study open to eligible people

An arteriovenous malformation is a tangle of blood vessels connecting arteries and veins. UCSF is currently enrolling patients in a registry to study hereditary hemorrhagic telangiectasia, a condition linked to these malformations. This registry collects information to improve understanding of patient outcomes.

Showing trials for

  • Comprehensive HHT Outcomes Registry of the United States (CHORUS)

    open to all eligible people

    The Comprehensive HHT Outcomes Registry of the United States (CHORUS) is an observational registry of patients diagnosed with Hereditary Hemorrhagic Telangiectasia (HHT). The purpose of this study is to better understand HHT, the symptoms and…

    San Francisco, California and other locations

Our lead scientists for Arteriovenous Malformation research studies include .

Last updated: